ArticleJCI insight2019

eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.

David Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.